0.000USD0.000Pre-market 07/24, 09:30 (ET)
6.14BMarket Cap
LossP/E TTM
Key Figures
46.820Open
49.500High
2.99MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.34%Turnover Ratio
47.050Prev. Close
46.820Low
115.00MTurnover
LossP/E Static
7.71P/B
0.00%Div Yield TTM
-2.36%ROA
28.17052wk High
1.00Volume Ratio
-182.63MNet Profit
127.69MShares
-0.1738EPS TTM
2.11Beta
-2.98%ROE
8.81052wk Low
5.70%Amplitude
70.39%Gross Margin
6.14BMarket Cap
8.89Reward/Risk
4.05%Risk Rate
Currency: USD Updated: 2026-07-23 Key Insights
10X Genomics Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 38.46.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
10X Genomics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
10X Genomics Inc Highlights
StrengthsRisks
10X Genomics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
10X Genomics Inc Info
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Ticker SymbolTXG
Company10X Genomics Inc
CEOSaxonov (Serge Wilson)
Websitehttps://www.10xgenomics.com/
Shareholders
FAQs
What is the current price of 10X Genomics Inc (TXG)?
The current price of 10X Genomics Inc (TXG) is 48.10.
What is the symbol of 10X Genomics Inc?
The ticker symbol of 10X Genomics Inc is TXG.
What is the 52-week high of 10X Genomics Inc?
The 52-week high of 10X Genomics Inc is 28.17.
What is the 52-week low of 10X Genomics Inc?
The 52-week low of 10X Genomics Inc is 8.81.
What is the market capitalization of 10X Genomics Inc?
The market capitalization of 10X Genomics Inc is 6.14B.
Is 10X Genomics Inc (TXG) currently rated as Buy, Hold, or Sell?
According to analysts, 10X Genomics Inc (TXG) has an overall rating of Buy, with a price target of 38.46.
What is the Earnings Per Share (EPS TTM) of 10X Genomics Inc (TXG)?
The Earnings Per Share (EPS TTM) of 10X Genomics Inc (TXG) is -0.35.
